| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/10/2022 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 10k | $0.37 | $3.7k | | 06/10/2022 |
| 06/02/2021 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 10k | $3.75 | $37.5k | | 06/02/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 10k | $17.27 | $172.7k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 10k | $29.80 | $298k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 15k | $6.09 | $91.4k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 20k | $4.14 | $82.8k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 12.5k | $22.15 | $276.9k | | 04/16/2021 |
| 04/16/2021 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Disposition | Stock Option (right to buy) | 12.5k | $12.70 | $158.8k | | 04/16/2021 |
| 06/15/2020 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 15k | $0.85 | $12.8k | | 06/15/2020 |
| 05/14/2020 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 20k | $4.14 | $82.8k | | 05/14/2020 |
| 06/19/2019 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 15k | $7.54 | $113.1k | | 06/19/2019 |
| 06/10/2019 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 15k | $6.09 | $91.4k | | 06/10/2019 |
| 03/08/2019 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 10k | $13.51 | $135.1k | | 03/08/2019 |
| 06/27/2018 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 15k | $28.15 | $422.2k | | 06/27/2018 |
| 05/10/2018 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 10k | $17.27 | $172.7k | | 05/10/2018 |
| 05/31/2017 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 15k | $13.80 | $207k | | 05/31/2017 |
| 05/10/2017 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 10k | $29.80 | $298k | | 05/10/2017 |
| 11/09/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Exercise | Stock Option (right to buy) | 4.1k | $7.26 | $29.5k | | 11/09/2016 |
| 11/09/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Exercise | Stock Option (right to buy) | 4.1k | $5.54 | $22.5k | | 11/09/2016 |
| 11/09/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Sale | Common Stock | 8.1k | $55.30 | $449.6k | | 11/09/2016 |
| 05/19/2016 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Grant | Stock Option (right to buy) | 10k | $42.25 | $422.5k | | 05/19/2016 |
| 05/31/2013 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 15k | $1.71 | $25.6k | | 05/31/2013 |
| 12/14/2012 | BIOCRYST PHARMACEUTICALS INC | BCRX | Purchase | Common Stock | 20k | $1.51 | $30.2k | | 12/14/2012 |
| 05/23/2012 | BIOCRYST PHARMACEUTICALS INC | BCRX | Grant | | 15k | $3.32 | $49.8k | | 05/23/2012 |
| 11/18/2011 | BIOCRYST PHARMACEUTICALS INC | BCRX | Purchase | Common Stock | 10k | $2.75 | $27.5k | | 11/18/2011 |
| 04/19/2011 | Acorda Therapeutics, Inc. | ACOR | Grant | Non-Employee Stock Option | 25k | $27.99 | $699.8k | | 04/19/2011 |